US Material Events SEC 8-K Filings — March 17, 2026

17-03-2026

Personalis, Inc. appointed Richard Chen as President on March 13, 2026, in addition to his existing roles as Executive Vice President, R&D, and Chief Medical Officer, based on the recommendation of CEO Christopher Hall, who previously served as President. In connection with the appointment, Dr. Chen's annual base salary will increase to $570,000 effective April 1, 2026, with his performance bonus target raised to 70% of base salary. He will also receive stock options for 37,500 shares and RSUs covering 6,250 shares, granted on March 15, 2026, under the 2019 Equity Incentive Plan.

• ·Richard Chen, age 55, has served as EVP R&D since March 2023, CMO since July 2021, SVP R&D from July 2021 to March 2023, and Chief Scientific Officer from November 2011 to July 2021.
• ·Stock options vest in equal monthly installments over 36 months; RSUs vest 1/6 on six-month anniversary of March 15, 2026, and bi-annually thereafter, subject to continuous service.
• ·Dr. Chen co-founded Ingenuity Systems in August 1997 and has been clinical faculty at Stanford since September 2011; holds B.S., M.S., and M.D. from Stanford.

17-03-2026

Eureka Acquisition Corp issued an interest-free promissory note for $150,000 to Marine Thinking Inc. on March 13, 2026, as disclosed in an 8-K filing on March 17, 2026. The note matures upon consummation of a Business Combination or the Company's term expiry and may be converted by the Payee into private units at $10 per unit. No period-over-period financial metrics are provided in the filing.

• ·Note governed by New York law
• ·Conversion notice required at least two business days prior to Business Combination closing
• ·No personal liability for officers, directors, employees, or stockholders
• ·Prospectus File No. 333-277780 referenced

17-03-2026

American Rebel Holdings Inc entered into a Securities Purchase Agreement issuing a promissory note to 1800 Diagonal Lending LLC with a principal amount of $124,200 purchased for $108,000 (including $16,200 OID), requiring total repayments of $147,487 over 15 monthly installments from April 15, 2026 to June 15, 2027 at an effective 15% interest rate. The note includes high default interest of 22%, acceleration to 150% of outstanding amounts upon events of default, and conversion rights into common stock (limited to 4.99% beneficial ownership, subject to Nasdaq 19.99% rule without stockholder approval), posing dilution risk. Prepayment is permitted at 95% of principal plus interest within the first 180 days without penalty.

• ·5-day grace period for payments; missed payment triggers Event of Default.
• ·Covenant restricts sale of significant assets without Holder consent to avoid shell company status.
• ·Events of Default include failure to pay (after 5 business days notice), covenant breaches (after 20 days notice), bankruptcy, delisting from Exchanges, non-compliance with Exchange Act reporting.
• ·Conversion rights exercisable only after Event of Default; Notice of Conversion must be before 6pm NY time.
• ·Prepayment requires 3 Trading Days prior notice; no partial prepayments except as specified.

17-03-2026

On March 15, 2026, Sean Smith resigned as Chief Accounting Officer of QXO, Inc., effective immediately, to pursue employment closer to his family, and agreed to serve in an advisory role until June 30, 2026, with continued compensation including prorated salary, bonus, and equity vesting. The departure is not due to any disagreements on accounting principles, financial statements, or internal controls. On March 16, 2026, Robert Loughran was appointed as Interim Chief Accounting Officer, effective immediately, while the company searches for a permanent successor.

• ·No family relationships between Mr. Loughran and any directors or executive officers.
• ·No arrangements or understandings pursuant to which Mr. Loughran was selected as an officer.
• ·No material transactions involving Mr. Loughran subject to Item 404(a) of Regulation S-K.
• ·Mr. Loughran's prior roles: Partner at Elm Street Advisors (since 2023), CFO at Greenidge Generation Holdings (Jan 2022-Oct 2023), CAO at Greenidge (Jun 2021-Jan 2022), VP Corporate Controller at Tronox Holdings PLC (Apr 2018-Jun 2020), various senior roles at Avon including Group VP CAO (Mar 2016-Mar 2019) and VP Corporate Controller (May 2012-Mar 2016).
• ·Mr. Loughran is a Certified Public Accountant with a BS from University of Connecticut.

17-03-2026

Tenon Medical, Inc. closed a private placement of senior convertible promissory notes with institutional and high net worth investors for gross proceeds of $4.3 million before placement agent fees. The notes have a 20% original issue discount, aggregate principal of $4.3 million, mature on September 11, 2026, and are convertible into common stock after a six-month anniversary at 80% of the VWAP for the prior three trading days. Net proceeds will support commercial expansion, product development, clinical studies, working capital, and general corporate purposes.

• ·Notes not registered under Securities Act of 1933; may not be offered or sold absent registration or exemption
• ·WallachBeth Capital, Inc. acted as placement agent
• ·National launch of Catamaran SI Joint Fusion System in October 2022
• ·Company formed in 2012

17-03-2026

Integrated Rail & Resources Inc. entered into a Securities Purchase Agreement on March 9, 2026, with B H, Inc., issuing 7,056 shares of Series A Convertible Preferred Stock to fully settle $705,589 in remaining outstanding debt, following a $750,000 cash payment on February 18, 2026, against an original $1,455,589 debt as of February 17, 2026. The Buyer joined the existing Registration Rights Agreement and released all claims related to the debt. The issuance relied on exemptions under Section 4(a)(2) and Rule 506 of Regulation D, with no cash consideration received by the Company.

• ·Debt originated from specific invoices: #200653 ($449,581, Dec 16, 2024), #205275 ($190,548, Jul 31, 2025), #205881 ($444,600, Sep 2, 2025), #206576 ($105,860, Sep 30, 2025), #207152 ($125,000, Oct 28, 2025), #208792 ($140,000, Jan 27, 2026)
• ·Preferred Shares have par value of $0.0001 per share
• ·Stifel, Nicolaus & Co. acted as advisor to the Company

17-03-2026

Clene Inc. entered into a third-year subaward agreement with New York University on March 13, 2026, for up to $8.0 million under the four-year $45.1 million NIH Grant, supporting the Expanded Access Program for CNM-Au8® treatment of amyotrophic lateral sclerosis from September 1, 2025, to August 31, 2026. This follows prior subawards of $7.3 million for Year 1 (September 2023-August 2024) with Columbia University and $8.0 million for Year 2 (September 2024-August 2025). Funds are reimbursable via monthly invoices, with either party able to terminate on 30 days' notice.

• ·Disbursement based on monthly invoices for reimbursement to Clene Nanomedicine, Inc.
• ·Company retains all rights to Background IP developed at private expense; no licenses granted to NYU or U.S. Government.
• ·Either party may terminate with 30 days' written notice.

17-03-2026

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI), a clinical-stage biopharmaceutical company developing CNS cancer therapies, appointed David Choi as Chief Accounting Officer effective March 13, 2026, to oversee accounting, financial reporting, internal controls, and governance as it advances Phase II trials. Mr. Choi brings over a decade of experience from Blythe Global Advisors, Grant Thornton, and Ernst & Young, including SEC reporting and SOX compliance. The appointment supports the company's growth with its NEO™ platform, including NEO100™ and NEO212™ under FDA Fast-Track status.

• ·Patent protections extending to 2038.
• ·Exclusively licensed worldwide patent portfolio from University of Southern California for NEO100, NEO212, and related products.
• ·Risk factors referenced in 10-Q for three months ended March 31, 2025.

17-03-2026

Bicycle Therapeutics reported Q4 and FY 2025 financial results showing collaboration revenue surging to $48.0M (Q4, +$44.3M YoY) and $72.6M (FY, +$37.3M YoY), with Q4 net loss improving to $20.2M from $51.9M, but FY net loss widening to $219.0M from $169.0M amid higher R&D expenses ($240.3M, +$67.3M YoY). Cash stood at $628.1M (down from $879.5M), extended to 2030 via 30% workforce reduction and ~50% op ex cut, while deprioritizing zelenectide (Duravelo-2 converted to Phase 2 despite 58-65% ORR) to focus on BT5528 and BRCs. Leadership changes include new COO Jennifer Perry and CCDO Alistair Milnes, with promotions for CFO Travis Thompson and CMO Michael Method.

• ·15-year contract with UK NDA for up to 400 tonnes of reprocessed uranium (RepU).
• ·Q4 R&D expenses $51.8M (+4% YoY), G&A $20.9M (-3.2% YoY).
• ·Plans to discontinue internal development of BT7480 post combination data and seek partner.
• ·Phase 2 trial for nuzefatide in PDAC enrolling since March 2026.

17-03-2026

On March 12, 2026, Erin Nealy Cox resigned from the Board of Directors of Sally Beauty Holdings, Inc., effective immediately, as she transitions to a new role at Walmart, Inc. There was no disagreement between Ms. Nealy Cox and the Company leading to her resignation, and her term was scheduled to expire at the 2027 Annual Meeting of Stockholders. The Company thanked her for her service and leadership.

17-03-2026

Redwire Corporation (NYSE: RDW) elected The Honorable Frank Calvelli to its Board of Directors, effective March 12, 2026, as announced in a press release dated March 17, 2026. Calvelli, with over 36 years of experience including as Assistant Secretary of the Air Force for Space Acquisition and Integration and Principal Deputy Director of the National Reconnaissance Office, brings expertise in U.S. Space Force programs and national security space acquisitions. Redwire Chairman and CEO Peter Cannito highlighted Calvelli's value for the company's growth in delivering capabilities for U.S. warfighters.

• ·Calvelli earned a bachelor’s degree in computer and information sciences from the State University of New York at Potsdam and an MBA from Loyola College in Baltimore, Maryland.
• ·Media Contact: Tere.Riley@rdw.com; Investors: Investorrelations@rdw.com

17-03-2026

Frontdoor, Inc. (NASDAQ: FTDR) announced the unanimous election of Dennis Howard to its Board of Directors and appointment to the Audit Committee, effective March 17, 2026. Howard, currently Managing Director, Chief Technology, Operations, and Data Officer at Charles Schwab, brings over 30 years of experience in IT, cybersecurity, operations, and innovation from roles at Charles Schwab and Visa Inc. The company, with over 55 years of experience, serves more than 2.1 million members, handling 3.8 million service requests annually through a network of 17,000 contractors.

• ·Howard joined Charles Schwab in September 2014 as Senior Vice President of core technology solutions.
• ·Served as Executive Vice President and Chief Information Officer at Charles Schwab from 2016-2025.
• ·12-year tenure at Visa Inc. in various IT roles.
• ·Bachelor's degree from University of Texas at San Antonio; Master's from Baylor University.
• ·Howard will stand for re-election at Frontdoor's 2026 annual meeting of stockholders.

17-03-2026

On March 17, 2026, Churchill Capital Corp XI appointed Paul Lapping and Stephen Murphy as directors, effective immediately, with both joining the compensation and audit committees; Lapping replaced William Sherman as Audit Committee chairperson, though Sherman remains a member. The Board expanded its first class of directors, whose terms expire at the first annual general meeting. The Company entered into director agreements with Lapping, Murphy, and Sherman providing $75,000 annual cash compensation per director, starting April 1, 2026.

• ·Paul Lapping, age 63, brings SPAC board experience from Churchill IX and X, prior CFO roles in SPACs, and private equity background.
• ·Stephen Murphy, age 62, has SPAC experience from Churchill IX, X, VI, and VII, plus investment banking at Salomon Brothers and Citigroup.
• ·New directors signed joinder to December 16, 2025 letter agreement waiving certain redemption rights and committing to vote in favor of initial business combination.
• ·No family relationships or related-party transactions involving new directors.

17-03-2026

Parsons Corporation (NYSE: PSN) announced the promotion of Soo Lagasse to Chief Human Resources Officer (CHRO) effective April 1, 2026, succeeding Susan Balaguer, who will retire by the end of May 2026 after nearly five years transforming the HR function. Balaguer achieved hiring records, attrition goals, and aligned benefits and leadership development with the 'People First' culture. Lagasse, who joined in 2021 with three decades of experience, led record hiring quarters, expanded university/intern programs, and enhanced global mobility.

• ·Lagasse joined Parsons in 2021.
• ·Balaguer served nearly five years and specifically four and a half years in quoted remarks.
• ·Media contact: Bernadette Miller +1 980.253.9781 Bernadette.Miller@parsons.com
• ·IR contact: Dave Spille +1 703.775.6191 Dave.Spille@parsons.us
• ·Parsons operates in national security and global infrastructure markets including cyber/electronic warfare, space/missile defense, transportation, water/environment, urban development, and critical infrastructure protection.

17-03-2026

Hinge Health, Inc. appointed Tyler Sloat as a Class I Director effective March 16, 2026, with his term expiring at the 2026 annual stockholder meeting; he was also appointed Chair of the Compensation Committee and a member of the Audit Committee. Mr. Sloat, current COO of Freshworks Inc. (since August 2024) and former CFO of Zuora Inc. (2010-2020), will receive standard non-employee director compensation including an initial $400,000 RSU award vesting over three years and pro-rated annual cash fees of $65,000 (elected as RSUs). No arrangements, family relationships, or related-party transactions were disclosed.

• ·Mr. Sloat holds a B.A. in Economics from Boston College and an M.B.A. from Stanford University Graduate School of Business; registered (inactive) CPA in California.
• ·RSUs vest annually over three years or in full upon Change in Control, subject to continued service.
• ·Standard indemnification agreement to be entered with Mr. Sloat.

17-03-2026

Peloton Interactive, Inc. (PTON) appointed Sarah Robb O’Hagan as Chief Content and Member Development Officer, effective April 1, 2026, reporting to President and CEO Peter Stern, to accelerate content innovation, member engagement, and the shift to a connected wellness strategy targeting sustainable profitable growth. She succeeds Jen Cotter, who is departing after seven years but will serve as an advisor through mid-August 2026. Robb O’Hagan brings extensive experience from CEO of EXOS, President of Gatorade ($5B business turnaround), and roles at Equinox, Nike, Flywheel Sports, and Strava.

• ·Peloton founded in 2012 and headquartered in New York City
• ·Peloton has millions of Members across the US, UK, Canada, Germany, Australia, and Austria
• ·Robb O’Hagan named one of Fast Company’s 'Most Creative People in Business' and Forbes’ 'Most Powerful Women in Sports'

17-03-2026

Nexentis Technologies Inc. (formerly N2OFF, Inc.) completed the closing of a Securities Exchange Agreement on March 15, 2026, transferring approximately 98% of its ownership in Save Foods Ltd. to Voice Assist, Inc. in exchange for 19.99% of Voice Assist's common stock on a fully-diluted basis. The company also maintains a Services Agreement with Voice Assist for advisory services, entitling it to deferred cash up to a $1M cap, royalties on new projects, and a share of Ecolab Gross Proceeds through at least 2026.

• ·Agreement originally dated January 13, 2026, with prior disclosure in 8-K filed that date.
• ·Services Agreement term through calendar year 2026 with extension rights until consideration fully received.
• ·Exhibits include Securities Exchange Agreement (10.1) and Services Agreement (10.2), incorporated by reference from January 13, 2026 8-K.

17-03-2026

Indivior Pharmaceuticals, Inc. issued $500M principal amount of 0.625% Convertible Senior Notes due 2031 on March 17, 2026, including $50M from the full exercise of the initial purchasers' option, providing low-cost financing at 0.625% interest payable semi-annually starting September 15, 2026. Proceeds were used to fully prepay and terminate a prior Note Purchase Agreement dated November 4, 2024 (amended January 26, 2026). The notes introduce potential equity dilution from up to 16.2M shares issuable upon conversion at an initial rate of 24.0033 shares per $1,000 principal (35% premium over March 12, 2026 closing price).

• ·Notes mature March 15, 2031; convertible starting December 16, 2030 at any time, earlier upon certain events.
• ·Redemption possible on or after March 20, 2029 if stock price exceeds 130% of conversion price for specified periods.
• ·Fundamental Change repurchase right at principal plus accrued interest.
• ·Events of Default include payment defaults, covenant breaches, and acceleration of $55M+ indebtedness.

17-03-2026

Drugs Made In America Acquisition II Corp. (DMIIU), a SPAC listed on NASDAQ, entered into a non-binding Letter of Intent (LOI) effective March 5, 2026, with Alpha Multi Family Office (Investor) and S.E.E. Capital Partners Ltd. (Transaction Advisor) for a proposed $1.5M Senior Convertible Note to provide bridge financing for operational expenses and pursuit of a business combination. The funds will be held in escrow and convertible into discounted preferred equity upon events like execution or closing of a business combination agreement. No definitive agreements have been executed yet, and the LOI includes exclusivity for negotiations.

• ·LOI governed by laws of the State of Israel with exclusive jurisdiction in Tel Aviv courts.
• ·Conversion triggers include execution of definitive business combination agreement, closing of business combination, or restructuring of sponsor/capital structure.
• ·In case of no business combination, note subject to repayment or alternative consideration per definitive agreements.
• ·SEC 8-K filed March 17, 2026, covering Items 1.01, 2.03, 8.01, 9.01.

17-03-2026

Mangoceuticals, Inc. (NASDAQ: MGRX) announced it filed a civil lawsuit in Texas state court against former vendor Clarity Ventures, Inc., seeking damages exceeding $73 million for allegedly failing to deliver a functional HIPAA-compliant ERP and eCommerce platform. Clarity has asserted counterclaims for unpaid invoices, which the company disputes as unwarranted since all required payments were made. The company has since developed its own proprietary telehealth and eCommerce platform internally, which management states has improved customer acquisition, order fulfillment, and operating performance, though all claims remain unproven in court.

• ·Lawsuit filed in Texas state court.
• ·Company's current platform developed internally without reliance on Clarity’s technology.
• ·References to SEC filings: Annual Report on Form 10-K for year ended December 31, 2024; Quarterly Report on Form 10-Q for quarter ended September 30, 2025.

17-03-2026

Taylor Morrison Home Corp announced that Board member David Merritt notified the company of his decision to retire from the Board effective at the 2026 Annual Meeting of Stockholders, with no disagreements on operations, policies, or practices. In connection, the Board approved reducing its size from nine to eight members.

• ·Event reported on March 11, 2026; filing dated March 17, 2026.
• ·Common Stock trades as TMHC on New York Stock Exchange.

17-03-2026

Frontier Airlines, a subsidiary of Frontier Group Holdings, Inc., entered Amendment No. 20 with Airbus S.A.S. deferring delivery of 69 A320neo family aircraft from 2027-2030 to 2031-2033, providing potential liquidity relief. Separately, it signed an Early Return Agreement with AerCap Holdings N.V. to terminate leases on 24 operating A320neo aircraft, reducing $400M in lease assets and liabilities, but expecting $125-175M in non-cash charges and $75-95M in cash charges in Q1/Q2 2026. AerCap also committed to 10 future sale-leaseback transactions for 2028-2029 deliveries.

• ·Leases for the 24 A320neo aircraft were originally scheduled to expire in 2-8 years.
• ·Non-cash charges primarily from write-off of prepaid maintenance and accelerated depreciation.
• ·Cash charges largely settled in 2028-2029.

17-03-2026

Navitas Semiconductor Corporation disclosed the departure of Todd Glickman, former Senior Vice President, Chief Financial Officer, and Treasurer, who will serve as a consultant until the Transition Date of March 30, 2026, to ensure a smooth handover. Tonya Stevens will become the incoming Chief Financial Officer and Treasurer effective March 30, 2026. On March 13, 2026, the company accelerated the vesting of 211,528 previously unvested restricted stock units for Glickman, originally scheduled for September 20, 2026.

• ·Previously disclosed in 8-K filings on February 24, 2026 and March 11, 2026
• ·Departure described as mutual decision to pursue new opportunities
• ·Report signed by Chris Allexandre on March 17, 2026

17-03-2026

Coursera, Inc. appointed Michael Foley, age 52, as permanent Senior Vice President, Chief Financial Officer, and Treasurer effective March 16, 2026, following his interim role. The new offer letter sets his annual base salary at $475,000, target annual bonus at 70% of base salary with a 2026 minimum of $200,000, and grants 350,000 RSUs vesting over four years starting February 15, 2027, plus 350,000 PSUs tied to 2026 financial goals. No family relationships, related transactions, or other arrangements were disclosed.

• ·RSUs vest 25% on February 15, 2027, remainder in equal quarterly installments.
• ·PSUs subject to 2026 financial performance certification by HRC Committee, with 25% vesting on February 15, 2027 if eligible.
• ·Mr. Foley participates in Amended and Restated Executive Severance Plan as Class A Executive effective March 16, 2026.
• ·Prior interim offer letter dated November 13, 2025 superseded.

17-03-2026

On March 11, 2026, Suzanne Seandel notified 8x8, Inc. of her resignation as Chief Accounting Officer and principal accounting officer, effective at a mutually agreeable date expected in mid-April 2026, not due to any disagreement with company operations, policies, or practices. The company plans a consulting arrangement with Ms. Seandel through May 31, 2026, and has commenced a search for her successor. Effective the separation date, Kevin Kraus, the current Chief Financial Officer, will be appointed principal accounting officer with no new compensatory agreements.

• ·Kevin Kraus, age 56, was appointed permanent CFO on June 5, 2023, after serving as Interim CFO from November 2022 to June 2023 and SVP of Finance since October 2019.
• ·Prior to 8x8, Kevin Kraus was VP of Finance at Imperva (2018-2019) and Senior Director of Finance at Gigamon (2015-2017).
• ·Mr. Kraus holds a bachelor’s degree in accounting from Rutgers University and an MBA from Pennsylvania State University.
• ·No family relationships or material conflicts of interest for Mr. Kraus.

17-03-2026

On March 13, 2026, Jaisim Shah retired as CEO, President, and Director of Semnur Pharmaceuticals, Inc., resulting in the board size decreasing from six to five members, with no disagreements on company matters. Henry Ji, Ph.D., previously Executive Chairperson, was immediately appointed as new CEO and President, while Stephen Ma, former CFO, was named COO effective March 17, 2026, with no changes to their compensation. Shah received a separation agreement providing six months of base salary continuation at a $1.25M annual rate.

• ·Shah granted 90-day extension to exercise vested stock options.
• ·No family relationships or disclosable related party transactions under Item 404(a) for Ji or Ma beyond Scilex ties.
• ·Company is an emerging growth company trading on OTCQB.

17-03-2026

Orion Group Holdings, Inc. announced the retirements of independent board members Thomas N. Amonett (serving since 2007) and Margaret M. Foran (serving since 2019), effective at the Annual General Meeting on May 19, 2026, with the Board size decreasing from eight to six directors. Chairman Austin Shanfelter thanked them for their leadership contributions, including committee chairs, and expressed confidence in the Company's future positioning. Both retiring members highlighted their pride in the Company's transformation and strong management team.

• ·Filing date: March 17, 2026
• ·Annual General Meeting of Stockholders: May 19, 2026
• ·Company headquartered in Houston, Texas
• ·Contact: Margaret Boyce, 346-278-3762, mboyce@orn.net

17-03-2026

Kevin A. Lobo notified Parker-Hannifin Corporation on March 13, 2026, that he will not stand for reelection to the Board of Directors at the 2026 Annual Meeting of Shareholders due to his election to the Board of GE HealthCare Technologies Inc. Mr. Lobo, who has served as a director since 2013, stated that his decision was not due to any disagreement with the company's operations, policies, or practices. He is expected to continue serving until the expiration of his current term.

• ·Filing signed by Joseph R. Leonti on March 17, 2026

17-03-2026

On March 16, 2026, David W. Johnson resigned from the Board of Directors of Hilton Grand Vacations Inc. effective immediately, with no disagreement on operations, policies, or practices. In connection with the resignation, the Board size was reduced from 10 to 9 directors.

• ·Resignation reported in Form 8-K filed on March 17, 2026
• ·Company headquartered at 6355 MetroWest Boulevard, Suite 180, Orlando, Florida 32835

17-03-2026

On March 15, 2026, Susan B. McGee notified the Board of Goldman Sachs BDC, Inc. that she intends to resign from the Board and all committees thereof, effective March 31, 2026. The Company and Board expressed gratitude for her service and anticipate her contributions until the end of her tenure. The 8-K was filed on March 17, 2026, and signed by Co-Chief Executive Officers Vivek Bantwal and David Miller.

• ·Principal executive offices: 200 West Street, New York, New York 10282
• ·Registrant’s telephone number: (312) 655-4419
• ·Common Stock trading symbol: GSBD on The New York Stock Exchange

17-03-2026

TaskUs, Inc. (via subsidiary TU Bidco, Inc.) entered into a Second Amended and Restated Credit Agreement on March 11, 2026, establishing $500M in Restatement Date Term Loans and a $100M Revolving Credit Facility. Proceeds from the Term Loans will refinance all existing Term Loans and Revolving Loans under the prior agreement (dated September 7, 2022), fund a Restatement Date Distribution, and cover related fees and expenses. Existing Letters of Credit continue under the new agreement, with Revolving Facility proceeds available for working capital and general corporate purposes including permitted acquisitions.

• ·Original Credit Agreement dated September 25, 2019, amended April 30, 2021, and restated September 7, 2022.
• ·SEC 8-K filed March 17, 2026, covering Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), and 9.01 (Financial Statements and Exhibits).

17-03-2026

Fulgent Genetics, Inc. (NASDAQ: FLGT) completed the acquisition of certain assets of Bako Diagnostics and StrataDx for a total combined purchase price of approximately $56.9 million in cash, subject to post-closing adjustments, as previously announced on December 22, 2025. The deal expands Fulgent's laboratory services into specialty pathology and dermatopathology. While no immediate financial impacts are quantified, forward-looking statements note potential integration risks and challenges in realizing benefits.

• ·Acquisition previously announced on December 22, 2025.
• ·Piper Sandler & Co. acted as exclusive financial advisor and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. as legal counsel to Fulgent.
• ·EV Health Partners acted as exclusive financial advisor and Latham & Watkins LLP as legal counsel to Consonance Capital Partners, Bako Diagnostics, and StrataDx.
• ·Fulgent's Form 10-K for fiscal year ended December 31, 2025, filed February 27, 2026.

17-03-2026

Beazer Homes USA, Inc. entered into a third amendment to its senior unsecured revolving credit facility, increasing the aggregate commitment from $365M to $525M (a 43.8% expansion) and extending the maturity from March 15, 2028, to March 13, 2030. The amendment, arranged by JP Morgan Chase Bank, N.A., Royal Bank of Canada, Truist Securities, Inc., and Regions Capital Markets, enhances liquidity and financial flexibility to support multi-year goals for community growth, de-leveraging, and book value per share increase, per CFO David Goldberg. No declines or flat metrics reported in facility terms.

• ·Beazer Homes builds in 13 states nationwide.
• ·Headquartered in Atlanta, Georgia.

17-03-2026

Aterian, Inc. entered into Amendment No. 5 to its Credit and Security Agreement on March 13, 2026, reducing the Minimum Credit Party Liquidity covenant to $3.5 million effective through April 12, 2026. The reduction can be extended weekly at the company's option through May 9, 2026, subject to compliance with fee payment obligations. This amendment provides temporary covenant relief amid potential liquidity constraints.

• ·Original Credit and Security Agreement dated December 22, 2021
• ·Amendment filed on March 17, 2026

17-03-2026

DTE Electric Company, a subsidiary of DTE Energy Company, entered into a Primary Supply Agreement (PSA) and Clean Capacity Accelerator Agreement (CCAA) with Google LLC on March 16, 2026, to provide electric service to Google's future 1.0 gigawatt data center in southeast Michigan through December 2047. Under the CCAA, DTE Electric will deploy up to 480 megawatts of energy storage and 1,600 megawatts of renewable generation over a 20-year term, supported by approximately 300 megawatts of Zonal Resource Credits from Google at no cost. The agreements include minimum monthly charges, potential termination fees, and credit support from Alphabet Inc., with full details to be filed in the Q1 2026 10-Q.

• ·PSA term runs through December 2047 with extension options
• ·CCAA 20-year term with mutual extension options
• ·Data center located in southeast Michigan
• ·Customer's parent (Alphabet Inc.) provides credit support for both agreements
• ·Agreements to be fully filed in Form 10-Q for quarter ending March 31, 2026

17-03-2026

Alexander & Baldwin, Inc. (ALEX) has been taken private through the completion of an acquisition by a joint venture formed by MW Group, Blackstone Real Estate, and DivcoWest, valued at approximately $2.3 billion enterprise value including debt. Shareholders received $21.20 per share in cash, net of a $0.35 Q4 2025 dividend (resulting in $20.85 net), following approval at a special meeting on March 9, 2026. A&B's common stock has ceased trading on the NYSE and the company is now privately held.

• ·Transaction initially announced on December 8, 2025
• ·Shareholder approval at Special Meeting on March 9, 2026
• ·Q4 2025 dividend record date December 19, 2025; paid January 8, 2026
• ·A&B's 156-year history in Hawaiʻi real estate sectors including agricultural, transportation, tourism, construction, residential, and commercial

17-03-2026

Cyngn Inc. (NASDAQ: CYN) announced a $9.65M registered direct offering of 5,000,000 shares of Common Stock (or pre-funded warrants) priced at $1.93 per share under Nasdaq rules, with a single institutional investor acquiring over 90% and a high-net-worth individual the remainder. Gross proceeds are expected from the offering closing on or about March 17, 2026, to be used for general corporate purposes and working capital, resulting in approximately 16,896,493 shares outstanding post-closing assuming full exercise of pre-funded warrants. No prior share count or performance comparisons were provided in the filing.

• ·Shelf registration statement on Form S-3 (No. 333-290079) effective September 18, 2025.
• ·Annual report on Form 10-K filed with SEC on November 14, 2025.
• ·Pre-funded warrants exercisable immediately at $0.00001 per share.

17-03-2026

On March 12, 2026, ImageneBio, Inc. (NASDAQ: IMA) announced a mutual separation from Erin Butler, Senior Vice President, Finance & Administration and Principal Accounting Officer, effective March 20, 2026, with severance benefits per her October 21, 2024 agreement. Effective the same date, the board appointed Bob Lally, current Senior Vice President, Finance & Operations, as the new Principal Accounting Officer. No new compensatory arrangements, family relationships, or disclosable transactions were noted for Mr. Lally.

• ·Bob Lally served as SVP Finance & Operations at Ikena Oncology from December 2022 to July 2025; VP Finance (Feb 2019-Mar 2021) and COO (Mar 2021-Jun 2022) at Prevail Therapeutics; Executive Director Finance and Controller at Arsanis from May 2016 to March 2019.
• ·Holds B.S. in finance from University of Massachusetts, Lowell.
• ·Separation Agreement to reference Severance Rights Agreement filed as Exhibit 10.16 to 8-K on July 29, 2025.

17-03-2026

Duos Technologies Group, through Duos Edge AI, executed a definitive GPUaaS contract with Hydra Host expected to generate $176M in revenue over 36 months, $50M+ in annual revenue, $40M+ in annual EBITDA, and gross margins exceeding 80%, supported by an initial $18M customer prepayment. The agreement includes a 4.3MW high-power EDC deployment for a leading global tech company as anchor tenant, funded by the company's recent $65M public offering. This deal validates the High-Power EDC model, with additional sites under evaluation toward a 75MW long-term capacity goal.

• ·Manufacturing of EDCs underway with critical power modules ordered.
• ·CEO Doug Recker appointment effective April 1, 2026.
• ·Additional high-density power sites under active evaluation.

17-03-2026

Primoris Services Corporation announced on March 12, 2026, that Director John P. Schauerman will not stand for re-election and will retire from the Board at the 2026 Annual Meeting of Stockholders, expected on April 30, 2026. The retirement is not due to any disagreement with the Company, where he has served since 2016 after prior roles including CFO from February 2008 to February 2009. The Company will not seek a replacement, reducing the Board size to eight members effective at the Annual Meeting.

• ·Filing signed on March 17, 2026
• ·Common Stock trades as PRIM on New York Stock Exchange

17-03-2026

Israel Acquisitions Corp entered into a third amendment to its Business Combination Agreement (BCA) with Gadfin Ltd. and Gadfin Regev Holdings Ltd. on March 13, 2026, extending the termination date under Section 7.1(d) to April 15, 2026, while all other termination rights remain unchanged. This follows prior amendments dated January 26, 2025 (original BCA), July 2, 2025, and December 31, 2025. No financial terms were revised in this amendment.

• ·Securities trade on OTC Markets: Units (ISLUF), Class A ordinary shares (ISRLF), Redeemable warrants (ISLWF)
• ·Previous BCA filings: January 27, 2025 (original), July 3, 2025 (first amendment), March 9, 2026 (second amendment 8-K/A)

17-03-2026

Jefferson Capital, Inc.'s Board approved and ratified 2025 annual cash bonuses on March 11, 2025: $382,884 (100% of target) for CEO David Burton, totaling $3,795,973; $247,202 (86% of target) for Mark Zellmann, totaling $1,062,184; and $208,864 in performance-based commissions for Chief Commercial Officer Penelope Person (including $97,872 for Q4), totaling $633,060. This updates the 2025 Summary Compensation Table originally filed in the January 5, 2026 prospectus, where these incentive amounts were not yet determined.

• ·Prospectus filed January 5, 2026 (Registration Statement No. 333-292576) originally omitted 2025 bonuses and Q4 commissions.
• ·Company is an emerging growth company.
• ·Common stock (JCAP) registered on Nasdaq Global Select Market, $0.0001 par value.

17-03-2026

On March 12, 2026, Anthony Bacos, Chief Product and Technology Officer of Stitch Fix, Inc., notified the company of his intention to retire, effective August 1, 2026. The 8-K filing was submitted on March 17, 2026, under Item 5.02 for officer departure. No successor has been named in the filing.

• ·Stitch Fix, Inc. is incorporated in Delaware with I.R.S. Employer Identification No. 27-5026540 and principal offices at 1 Montgomery Street, Suite 1500, San Francisco, California 94104.
• ·Class A common stock trades under symbol SFIX on Nasdaq Global Select Market.